Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03928343

Ligand	Ligand name	Chain	PDB	Tanimoto
DXA	1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)-8,9-DIHYDROXY-7-(SEC-BUTYL)-ANTHRACENE	A,B	1CP8	0.7
D2C	(2S,4S,4AR,5AS,6S,11R,11AS,12R,12AR)-7-CHLORO-4-(DIMETHYLAMINO)-6,10,11,12-TETRAHYDROXY-1,3-DIOXO-1,2,3,4,4A,5,5A,6,11,11A,12,12A-DODECAHYDROTETRACENE-2-CARBOXAMIDE	A,D,M,N,Z	2F4V	0.79
629	[2-AMINO-3-(4-HYDROXY-PHENYL)-PROPIONYLAMINO]-(1,3,4,5-TETRAHYDROXY-4-HYDROXYMETHYL-PIPERIDIN-2-YL)- ACETIC ACID	A	1JIJ	0.7
DM5	IDARUBICIN	A,B,D	198D	0.71
DM5	IDARUBICIN	A	1D38	0.71
DM5	IDARUBICIN	A	1D67	0.71
DXB	1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)-8,9-DIHYDROXY-7-METHYL-ANTHRACENE	A,B	1BP8	0.7
DRA	11-DEOXY-BETA-RHODOMYCIN	A,B	1XDS	0.72
AKY		A,B,C,D	2IPI	0.71
MIY	(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE	A	2DRD	0.77
TAC	TETRACYCLINE	A,B,C,D,E,F,G,H,I,J,K,L	2HDN	0.86
TAC	TETRACYCLINE	A	2VKE	0.86
TAC	TETRACYCLINE	A	2TRT	0.86
TAC	TETRACYCLINE	B	2UXO	0.86
TAC	TETRACYCLINE	A,B,D,E,G,H,J,K,L,N,P,Q,R,T	1I97	0.86
TAC	TETRACYCLINE	A,D,H,N	1HNW	0.86
TAC	TETRACYCLINE	A,B	2HCJ	0.86
CTC	7-CHLOROTETRACYCLINE	A	1BJ0	0.8
CTC	7-CHLOROTETRACYCLINE	A,B	1BJY	0.8
CTC	7-CHLOROTETRACYCLINE	A	2FJ1	0.8
CTC	7-CHLOROTETRACYCLINE	A	1DU7	0.8
CTC	7-CHLOROTETRACYCLINE	A,B	3EGZ	0.8
CTC	7-CHLOROTETRACYCLINE	A	2TCT	0.8
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW2	0.7
ERT	METHYL (4R)-2-ETHYL-2,5,12-TRIHYDROXY-7-METHOXY-6,11-DIOXO-4-{[2,3,6-TRIDEOXY-3-(DIMETHYLAMINO)-BETA-D-RIBO-HEXOPYRANOSYL]OXY}-1H,2H,3H,4H,6H,11H-TETRACENE-1-CARBOXYLATE	A,B	1TW3	0.7
DM4	1-O-DEMETHYL-6-DEOXYDOXORUBICIN	A	1D37	0.72
NLX	(5A,17R)-4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-6-OXO-17-(2-PROPENYL)-MORPHINANIUM	A,B,C,D,E,F,G,H,I,J,K,L	1MX9	0.7
ATC	9-(N,N-DIMETHYLGLYCYLAMIDO)-6-DEOXY-6-DEMETHYL-TETRACYCLINE	A	1ORK	0.73
DM9	N-HYDROXYMETHYL-N-(2-METHOXYETHYL)-DAUNOMYCIN	A	482D	0.71
TDC	5A,6-ANHYDROTETRACYCLINE	A	2VKV	0.88
TDC	5A,6-ANHYDROTETRACYCLINE	A	2VPR	0.88
AOE	N-BUTYL-11-[(7R,8R,9S,13S,14S,17S)-3,17-DIHYDROXY-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-7-YL]-N-METHYLUNDECANAMIDE	A	1HJ1	0.72
AKA	10-DECARBOXYMETHYLACLACINOMYCIN A (DCMAA)	A	1Q0Z	0.72
NOD	N-ETHYLHYDROXY-DOXORUBICIN	A	385D	0.71
JE2	(R)-N-(2-METHYLBENZYL)-3-[(2S,3S)-2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO-4-PHENYLBUTANOYL]-5,5-DIMETHYL-1,3-THIAZOLIDINE-4-CARBOXAMIDE	A,B	1KZK	0.71
JE2	(R)-N-(2-METHYLBENZYL)-3-[(2S,3S)-2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO-4-PHENYLBUTANOYL]-5,5-DIMETHYL-1,3-THIAZOLIDINE-4-CARBOXAMIDE	B	1MSM	0.71
JE2	(R)-N-(2-METHYLBENZYL)-3-[(2S,3S)-2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO-4-PHENYLBUTANOYL]-5,5-DIMETHYL-1,3-THIAZOLIDINE-4-CARBOXAMIDE	A,B	2ANL	0.71
JE2	(R)-N-(2-METHYLBENZYL)-3-[(2S,3S)-2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO-4-PHENYLBUTANOYL]-5,5-DIMETHYL-1,3-THIAZOLIDINE-4-CARBOXAMIDE	B	1MSN	0.71
DXT	(4S,4AR,5S,5AR,6R,12AS)-4-(DIMETHYLAMINO)-3,5,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE	A	2O7O	0.9
TNC	4-DIMETHYLAMINO-1,10,11,12-TETRAHYDROXY-3-OXO-3,4,4A,5-TETRAHYDRO-NAPHTHACENE-2-CARBOXYLIC ACID AMIDE	A,B	1N5Q	0.83
AKT	10-DECARBOXYMETHYLACLACINOMYCIN T (DCMAT)	A	1Q0R	0.72
DM3	6-DEOXYDAUNOMYCIN	A	1D14	0.7
099	(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide	A,B	3HYG	0.71
CRH	1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)-8,9-DIHYROXY-7-METHYLANTHRACENE	A,B	146D	0.7
CRH	1,2-HYDRO-1-OXY-3,4-HYDRO-3-(1-METHOXY-2-OXY-3,4-DIHYDROXYPENTYL)-8,9-DIHYROXY-7-METHYLANTHRACENE	A,B	207D	0.7